Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells

Cancer Research

Volumn 69, Issue 13, 2009, Pages 5450-5457

  Jaramillo, Melba C ^a   Frye, Jennifer B ^a   Crapo, James D ^b   Briehl, Margaret M ^a   Tome, Margaret E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MESO TETRAKIS(N ETHYLPYRIDINIUM 2 YL)PORPHYRIN; PORPHYRIN; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL GROWTH; CONTROLLED STUDY; DRUG POTENTIATION; FOLLICULAR LYMPHOMA; GENETIC TRANSFECTION; GROWTH INHIBITION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYMUS LYMPHOMA;

ANIMALS; APOPTOSIS; CATALASE; CELL LINE, TUMOR; DEXAMETHASONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HYDROGEN PEROXIDE; LYMPHOMA; LYMPHOMA, FOLLICULAR; MICE; PORPHYRINS; SUPEROXIDE DISMUTASE; TRANSFECTION;

EID: 67650481198     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4031     Document Type: Article

References (54)

1. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002;9:6-19.
2. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004;11 Suppl 1:S45-55.
3. Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004;16:553-63.
4. Hillmann AG, Ramdas J, Multanen K, Norman MR, Harmon JM. Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo. Cancer Res 2000;60:2056-62.
5. Bachmann PS, Gorman R, Mackenzie KL, Lutze-Mann L, Lock RB. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005;105:2519-26.
6. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003;278:23861-7.
7. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002;3:932-9.
8. Miyashita T, Reed JC. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 1992;52:5407-11.
9. Bachmann PS, Gorman R, Papa RA, et al. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res 2007;67:4482-90.
10. Reed JC, Pellecchia M. Apoptosis-based therapies for hematologic malignancies. Blood 2005;106:408-18.
11. Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997;90:244-51.
12. Tome ME, Briehl MM. Thymocytes selected for resistance to hydrogen peroxide showaltered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Cell Death Differ 2001;8:953-61.
13. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 2001;61:2766-73.
14. 2 in cells and thereby their biological state. Free Radic Biol Med 2006;41:1338-50.
15. Rodriguez AM, Carrico PM, Mazurkiewicz JE, Melendez JA. Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H2.O(2). Free Radic Biol Med 2000;29:801-13.
16. Hodge DR, Xiao W, Peng B, Cherry JC, Munroe DJ, Farrar WL. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res 2005;65:6255-63.
17. van de Wetering CI, Coleman MC, Spitz DR, Smith BJ, Knudson CM. Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radic Biol Med 2008;44:1677-86.
18. Harris AW, Bankhurst AD, Mason S, Warner NL. Differentiated functions expressed by cultured mouse lymphoma cells: II. theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol 1973;110:431-8.
19. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J Biol Chem 1998;273:13245-54.
20. Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 1976;98:367-81.
21. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991;69:1476-86.
22. Turakhia S, Venkatakrishnan CD, Dunsmore K, et al. Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol 2007;293:H3111-21.
23. Siemankowski LM, Morreale J, Briehl MM. Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD. Free Radic Biol Med 1999;26:919-24.
24. Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 1995;10:1989-2000.
25. Iqbal J, Whitney P. Use of cyanide and diethyldithiocarbamate in the assay of superoxide dismutases. Free Radic Biol Med 1991;10:69-77.
26. Efferth T, Briehl MM, Tome ME. Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 2003;23:1231-5.
27. Tome ME, Lutz NW, Briehl MM. Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells. Biochim Biophys Acta 2003;1642:149-62.
28. Ridnour LA, Oberley TD, Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal 2004;6:501-12.
29. Batinic-Haberle I, Benov L, Spasojevic I, Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J Biol Chem 1998;273:24521-8.
30. Batinic-Haberle I, Spasojevic I, Hambright P, Benov L, Crumbliss AL, Fridovich I. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins. Inorg Chem 1999;38:4011-22.
31. Kachadourian R, Johnson CA, Min E, Spasojevic I, Day BJ. Flavin-dependent antioxidant properties of a new series of meso-N,N′-dialkyl- imidazolium substituted manganese(III) porphyrins. Biochem Pharmacol 2004;67:77-85.
32. Moeller BJ, Batinic-Haberle I, Spasojevic I, et al. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 2005;63:545-52.
33. Zhao Y, Chaiswing L, Oberley TD, et al. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res 2005;65:1401-5.
34. Day BJ, Patel M, Calavetta L, Chang LY, Stamler JS. A mechanism of paraquat toxicity involving nitric oxide synthase. Proc Natl Acad Sci U S A 1999;96:12760-5.
35. Cocheme HM, Murphy MP. Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 2008;283:1786-98.
36. Krall J, Bagley AC, Mullenbach GT, Hallewell RA, Lynch RE. Superoxide mediates the toxicity of paraquat for cultured mammalian cells. J Biol Chem 1988;263:1910-4.
37. Kachadourian R, Flaherty MM, Crumbliss AL, Patel M, Day BJ. Synthesis and in vitro antioxidant properties of manganese(III) β-octabromo-meso- tetrakis(4-carboxyphenyl)porphyrin. J Inorg Biochem 2003;95:240-8.
38. Fisher RI, Miller TP, O'Connor OA. Diffuse aggressive lymphoma. Hematol Am Soc Hematol Educ Program 2004;2004:221-36.
39. Perry MC, Anderson CM, Dorr VJ, Wilkes JD. Companion Handbook to the Chemotherapy Source Book. New York: Lippincott, Williams & Wilkins; 1999.
40. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-41.
41. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem 2004;279:25535-43.
42. Kalivendi SV, Konorev EA, Cunningham S, et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J 2005;389:527-39.
43. Jones SE, Grozea PN, Metz EN, et al. Superiority of Adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer 1979;43:417-25.
44. Singal PK, Deally CM, Weinberg LE. Subcellular effects of Adriamycin in the heart: a concise review. J Mol Cell Cardiol 1987;19:817-28.
45. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against Adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996;98:1253-60.
46. Tome ME, Johnson DB, Rimsza LM, et al. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 2005;106:3594-601.
47. Day BJ, Kariya C. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins. Toxicol Sci 2005;85:713-9.
48. Batinic-Haberle I, Spasojevic I, Fridovich I. Tetrahydrobiopterin rapidly reduces the SOD mimic Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl) porphyrin. Free Radic Biol Med 2004;37:367-74.
49. Ferrer-Sueta G, Hannibal L, Batinic-Haberle I, Radi R. Reduction of manganese porphyrins by flavoenzymes and submitochondrial particles: a catalytic cycle for the reduction of peroxynitrite. Free Radic Biol Med 2006;41:503-12.
50. Tse HM, Milton MJ, Piganelli JD. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic Biol Med 2004;36:233-47.
51. Tonomura N, McLaughlin K, Grimm L, Goldsby RA, Osborne BA. Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol 2003;170:2469-78.
52. Novac N, Baus D, Dostert A, Heinzel T. Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J 2006;20:1074-81.
53. Spasojevic I, Colvin OM, Warshany KR, Batinic-Haberle I. Newapproach to the activation of anti-cancer pro-drugs by metalloporphyrin-based cytochrome P450 mimics in all-aqueous biologically relevant system. J Inorg Biochem 2006;100:1897-902.
54. Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B. Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J 2002;367:729-40.